Why the study?
Does levosimendan improve haemodynamic stability and long-term prognosis in patients with acute heart failure compared to traditional inotropes?
Population
Patients with acute heart failure
Comparison
Calcium sensitisers (specifically levosimendan) vs Traditional inotropes
Design
Review
Authors
Loading...
May support hemodynamic use in acute HF without excess oxygen demand; leaves open prognostic superiority versus traditional inotropes.
Does levosimendan improve haemodynamic stability and long-term prognosis in patients with acute heart failure compared to traditional inotropes?
Levosimendan offers a unique dual mechanism of inotropy and vasodilation for acute heart failure, avoiding the increased oxygen consumption and arrhythmogenesis associated with traditional inotropes.
Leif Erhardt (2005) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: